-
VIRUS-LIKE PARTICLE VACCINE (VLP) FOR COVID-19 PREVENTION FOR PARENTERAL USE
2024-04-27
-
VIRUS-LIKE PARTICLES (VLP) VACCINE FOR PREVENTION OF COVID-19 FOR INTRANASAL USE
2024-04-27
-
METHOD OF PRODUCING 3-HYDROXY-1-(2-HYDROXYPHENYL)-7a-(1H-INDOL-3-YL)-4-PHENYL-1,7a-DIHYDRO-2H-PYRROLO(2,3-d)PYRIDAZINE-2,7(6h)-DIONE AS AGENT HAVING ANTI-TUBERCULOSIS ACTIVITY
2024-04-15
-
METHOD OF PRODUCING (E)-5-AMINO-3-HYDRAZONO-4-HYDROXY-1-(2-HYDROXYPHENYL)-6a-(1H-INDOL-3-yl)-4-PHENYLHEXAHYDROPYRROLO(3,4-b)PYRROLE-2,6-DIONE AS AGENT WITH ANTI-TUBERCULOSIS ACTIVITY
2024-04-15
-
METHOD OF PRODUCING N-(2-AMINOETHYL)-3-BENZOYL-4-HYDROXY-1-(2-HYDROXYPHENYL)-2-(1H-INDOL-3-YL)-5-OXO-2,5-DIHYDRO-1H-PYRROLE-2-CARBOXAMIDE AS AGENT HAVING ANTI-TUBERCULOSIS ACTIVITY
2024-04-15
-
METHOD OF PRODUCING N,N-DIETHYL-3-BENZOYL-4-HYDROXY-1-(2-HYDROXYPHENYL)-2-(1H-INDOL-3-YL)-5-OXO-2,5-DIHYDRO-1H-PYRROLE-2-CARBOXAMIDE HAVING ANTIMICROBIAL ACTIVITY
2024-04-15
-
USE OF 4-BENZOYL-3-HYDROXY-1-(2-HYDROXYPHENYL)-8-THIOXO-1,7-DIAZASPIRO(4.4)NON-3-ENE-2,6-DIONE AS AGENT HAVING ANTIMICROBIAL ACTIVITY
2024-04-15
-
USE OF 2-(2-CARBAMOTHIOYLHYDRAZONO)-4-OXO-4-(4-TOLYL)BUTANOIC ACID AS AGENT HAVING ANTIMICROBIAL ACTIVITY ON STAPHYLOCOCCUS AUREUS, ESCHERICHIA COLI CULTURES AND ANTIFUNGAL ACTIVITY ON CANDIDA ALBICANS CULTURES
2024-04-04
-
METHOD FOR PREDICTING DEVELOPMENT OF BRAINSTEM NEOPLASM IN HUMAN
2024-04-03
-
USE OF 9-AROYL-8-HYDROXY-6-(2-HYDROXYETHYL)-2-PHENYL-1-THIA-3,6-DIAZASPIRO(4.4)NON-2,8-DIENE-4,7-DIONES, HAVING ANTIBACTERIAL ACTIVITY ON THE CULTURE OF STAPHYLOCOCCUS AUREUS AND ANTIFUNGAL ACTIVITY ON THE CULTURE OF CANDIDA ALBICANS
2024-03-27
